AMA
Kamel S, Alaty W, Rashad H, et al. One-year single-center follow-up study of ustekinumab and vedolizumab use in inflammatory bowel disease Egyptian patients as second-line therapy after anti-TNF failure. Gastroenterology Review/Przegląd Gastroenterologiczny. 2025;20(4):430-438. doi:10.5114/pg.2025.156473.
APA
Kamel, S., Alaty, W., Rashad, H., Fathy, D., Abdel-Samiee, M., & Hindy, I. et al. (2025). One-year single-center follow-up study of ustekinumab and vedolizumab use in inflammatory bowel disease Egyptian patients as second-line therapy after anti-TNF failure. Gastroenterology Review/Przegląd Gastroenterologiczny, 20(4), 430-438. https://doi.org/10.5114/pg.2025.156473
Chicago
Kamel, Shimaa, Waleed Hamed Abd Alaty, Heba Rashad, Dina Fathy, Mohamed Abdel-Samiee, Ibrahim Hindy, and Ahmed Shaban et al. 2025. "One-year single-center follow-up study of ustekinumab and vedolizumab use in inflammatory bowel disease Egyptian patients as second-line therapy after anti-TNF failure". Gastroenterology Review/Przegląd Gastroenterologiczny 20 (4): 430-438. doi:10.5114/pg.2025.156473.
Harvard
Kamel, S., Alaty, W., Rashad, H., Fathy, D., Abdel-Samiee, M., Hindy, I., Shaban, A., and Askar, S. (2025). One-year single-center follow-up study of ustekinumab and vedolizumab use in inflammatory bowel disease Egyptian patients as second-line therapy after anti-TNF failure. Gastroenterology Review/Przegląd Gastroenterologiczny, 20(4), pp.430-438. https://doi.org/10.5114/pg.2025.156473
MLA
Kamel, Shimaa et al. "One-year single-center follow-up study of ustekinumab and vedolizumab use in inflammatory bowel disease Egyptian patients as second-line therapy after anti-TNF failure." Gastroenterology Review/Przegląd Gastroenterologiczny, vol. 20, no. 4, 2025, pp. 430-438. doi:10.5114/pg.2025.156473.
Vancouver
Kamel S, Alaty W, Rashad H, Fathy D, Abdel-Samiee M, Hindy I et al. One-year single-center follow-up study of ustekinumab and vedolizumab use in inflammatory bowel disease Egyptian patients as second-line therapy after anti-TNF failure. Gastroenterology Review/Przegląd Gastroenterologiczny. 2025;20(4):430-438. doi:10.5114/pg.2025.156473.
